According to a recent study published in "Annals of Rheumatic Diseases" Journal, Pharmaceutical-grade Chondroitin sulfate (800mg/day) was found to possess similar efficacy as celecoxib in managing Knee Osteoarthritis (OA).
Pain Management
News
June 5, 2018
The results of the latest study demonstrated the effectiveness of Leflunomide (LEF) in arthritis patients with failed methotrexate response. The investigators found LEF to be devoid of serious adverse effects and it can be considered a reasonable and cost-effective treatment option before initiating biological therapy.
8min read
News
June 5, 2018
The customizable thin insoles provided a significant reduction in pain produced by walking, confirms the recent study published in "Musculoskeletal care" Journal.
7min read
News
June 5, 2018
Novel Serum Biomarkers Differentiate Psoriatic Arthritis from Psoriasis without Psoriatic Arthritis.
A recent study published in "Arthritis Care and Research" revealed that the combination of ITGβ5, M2BP, and C-Reactive protein (CRP) level distinguishes psoriatic arthritis (PsA) from those with psoriasis without psoriatic arthritis (PsC). Also, the combination was found to be better than CRP level alone.
7min read
News
May 30, 2018
“Patient navigators do not ameliorate oral DMARD adherence”, confirms latest study published in Arthritis Care & Research Journal
9min read
- 1 of 147
- ››